SELECT MEDICAL HOLDINGS CORP — Form 8-K
Filed July 1, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 72/100
What the filing says
Select Medical amended its credit agreement on June 30, 2026, establishing a new $1,000,000,000 Tranche B-3 Term Loan Facility to finance the acquisition of Select Medical Holdings by WCAS XIV, L.P. and management investors. JPMorgan Chase Bank is the sole lender on this tranche. The acquisition is expected to close concurrent with the initial borrowing of the Tranche B-3 loans, with equity investors required to contribute at least 25% of total consideration (debt plus equity).
Why this rating
Major leveraged acquisition materially increases company debt. $1B new debt represents ~63% of current market cap, highly material. Significant business change through change of control, but already reflected in market expectations given public merger agreement.
View original filing on SEC.gov ↗
See more from July 1, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.